StockWatch
·

Apimeds Pharmaceuticals US, Inc.

Ticker: 1894525

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-28.24-4.9218.4041.72Q2 FY26Q3 FY26

Margin Trend

percentage
OPM %NPM %
-130.00-43.3343.33130.00Q2 FY26Q3 FY26
PeriodQ3 FY26Q2 FY26
INCOME
Revenue2.90+935.7%0.28
Total Income2.90+935.7%0.28
EXPENSES
Expenditure0.87-95.7%20.46
PROFIT
Net Profit33.65+266.8%-20.17
KEY METRICS
OPM %70.03%—
NPM %100.00%+200.00pp-100.00%
EPS19.13—

Corporate Events

Board MeetingAPUS
2026
29Sep

Board Meeting

Erick Frim resigned as Interim Chief Financial Officer and E…

SEC Filing ↗
Board MeetingAPUS
2026
10Sep

Board Meeting

The Board composition has been restructured following an ame…

SEC Filing ↗
Board MeetingAPUS
2026
5Aug

Board Meeting

Appointment of Dr. Christopher Kim as Chief Scientific Offic…

SEC Filing ↗
Stock SplitAPUS
2026
24Jul

1:10

SEC Filing ↗
Stock SplitAPUS
2026
24Jul

1:10

SEC Filing ↗
Board MeetingAPUS
2026
4May

Board Meeting

Appointment of Sungjoon Chae as Co-Chief Executive Officer …

SEC Filing ↗
Board MeetingAPUS
2026
24Apr

Board Meeting

Apimeds Pharmaceuticals US, Inc. entered into a Confidential…

SEC Filing ↗
Board MeetingAPUS
2026
20Mar

Board Meeting

Clarification that previously reported purported removals of…

SEC Filing ↗